Clinical trial
Sodium Glucose Cotransporter 2 Inhibitors in Patients Without Diabetes With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
NCT06903754 is registered in ClinicalTrials.gov with Mohammed VI University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sodium Glucose Cotransporter 2 Inhibitors in Patients Without Diabetes With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- Lead sponsor
- Mohammed VI University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2021
- Completion date
- December 31, 2024
- Enrollment
- 450 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute coronary syndromes, heart failure